Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR664B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARIH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VDAC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSL24D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAGLN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FKBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
WDR46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNHG16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RANBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR9-3HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFIB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARPC5L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on